New Ray Medicine International Holding Limited 新銳醫藥國際控股有限公司

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

HKD '000

Directors

1 Chu, Xueping 禇雪平 ED 360 1,205 1,565
2 Huo, Zhihong 霍志宏 ED 360 360
3 Leung, Eddie Chi Kin 梁志堅 INED 240 240
4 Li, Ivy Sin Ming 李倩明 INED 240 240
5 Sy, Sunny Lai Yin 施禮賢 INED 240 240
6 Wang, Qiuqin 王秋勤 Ch, CEO 960 222 21 1,205 2,408
Total 2,400 222 0 21 2,410 5,053

Main board pay history

Click on the year-end to see the pay details.

HKD'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 2,685 355 0 43 0 3,083 Report
2023-12-31 2,670 369 0 41 0 3,080 Report
2022-12-31 2,400 222 0 21 2,410 5,053 Report
2021-12-31 2,683 220 0 20 0 2,923 Report
2020-12-31 3,240 174 0 11 0 3,425 Report
2019-12-31 1,800 1,098 0 16 0 2,914 Report
2018-12-31 917 5,018 0 60 0 5,995 Report
2017-12-31 315 9,659 0 105 0 10,079 Report
2016-12-31 356 8,687 0 110 1,137 10,290 Report
2015-12-31 366 4,529 0 146 0 5,041 Report
2014-12-31 366 1,679 0 153 0 2,198 Report
2013-12-31 56 817 0 91 0 964 Report
Total 17,854 32,827 0 817 3,547 55,045

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top